Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Molecular Profile | KIT A502_Y503dup PTEN del exon1-2 |
| Therapy | Everolimus + Imatinib |
| Indication/Tumor Type | gastrointestinal stromal tumor |
| Response Type | predicted - sensitive |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| KIT A502_Y503dup PTEN del exon1-2 | gastrointestinal stromal tumor | predicted - sensitive | Everolimus + Imatinib | Case Reports/Case Series | Actionable | In a clinical case study, treatment with the combination of Gleevec (imatinib) and Afinitor (everolimus) resulted in stable disease lasting 8.6 months in a patient with recurrent gastrointestinal stromal tumor harboring KIT A502_Y503dup (reported as Y503_F504insAY) and PTEN exon1-2 deletion, along with CDKN2A/B copy number loss (PMID: 40700673). | 40700673 |
| PubMed Id | Reference Title | Details |
|---|---|---|
| (40700673) | Personalized N-of-1 Combination Therapies for Advanced Gastrointestinal Stromal Tumors. | Full reference... |